About
Vir A/S develops microbiome-based therapeutics targeting viral infections and immune system modulation.
Explore Vir A/S's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Vir A/S develops microbiome-based therapeutics targeting viral infections and immune system modulation.
Funding rounds, investor list, and risk signals — unlock with a subscription.